Publications by authors named "Hugo Maas"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

24

Total Likes

42

Extended Reach

85,875

Social Features

14
D
Dabigatran versus warfarin in patients with mechanical heart valves.
John W Eikelboom, Stuart J Connolly, Martina Brueckmann, Christopher B Granger, Arie P Kappetein, Michael J Mack, Jon Blatchford, Kevin Devenny, Jeffrey Friedman, Kelly Guiver

September 2013

Videos about Article: user user

2 30 12 6 17

View All Article and Social Media Activity
A
An introduction to causal inference for pharmacometricians.
James A Rogers, Hugo Maas, Alejandro Pérez Pitarch

CPT Pharmacometrics Syst Pharmacol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients.
Daniel Moj, Hugo Maas, André Schaeftlein, Nina Hanke, José David Gómez-Mantilla

Clin Pharmacokinet· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Exposure-Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib.
Ronald Niebecker, Hugo Maas, Alexander Staab, Matthias Freiwald, Mats O Karlsson

CPT Pharmacometrics Syst Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics/Pharmacodynamics of Dabigatran 75 mg Twice Daily in Patients With Nonvalvular Atrial Fibrillation and Severely Impaired Renal Function.
Jack L Martin, Habib Esmaeili, Raymond C Manuel, Michaela Petrini, Sabrina Wiebe, Hugo Maas

J Cardiovasc Pharmacol Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical Trials.
Hugo Maas, Savion Gropper, Fenglei Huang, Joachim Stangier, Igor Tartakovsky

Thromb Haemost· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism.
Jacqueline M L Halton, Anne-Caroline Picard, Ruth Harper, Fenglei Huang, Martina Brueckmann, Hugo Maas

Thromb Haemost· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of Dabigatran 75 mg b.i.d. in Patients With Severe Chronic Kidney Disease.
Judith Kooiman, Tom van der Hulle, Hugo Maas, Sabrina Wiebe, Stephan Formella

J Am Coll Cardiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of absorption rate and lag time to the onset of action in migraine.
Hugo J Maas, Marc A H Spruit, Meindert Danhof, Oscar E Della Pasqua

Clin Pharmacokinet· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of responses in migraine modelling using hidden Markov models.
Vladimir V Anisimov, Hugo J Maas, Meindert Danhof, Oscar Della Pasqua

Stat Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model-based approach to treatment comparison in acute migraine.
Hugo J Maas, Meindert Danhof, Oscar Della Pasqua

Br J Clin Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
Klaas P Zuideveld, Jasna Rusiç-Pavletiç, Hugo J Maas, Lambertus A Peletier, Piet H Van der Graaf

J Pharmacol Exp Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs.
Lena E Friberg, Anja Henningsson, Hugo Maas, Laurent Nguyen, Mats O Karlsson

J Clin Oncol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
Klaas P Zuideveld, Nicoline Treijtel, Hugo J Maas, Josy M Gubbens-Stibbe, Lambertus A Peletier

J Pharmacol Exp Ther· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis